Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

Abstract

Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor volume in most patients. (Funded by Plexxikon; ClinicalTrials.gov number, NCT01004861.).